JANINE RUPPERT: Open Payments
NPI 1225547581 · HACKETTSTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 33 payments from 15 companies in 2025. Trend: 2023 $503 · 2024 $735 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $216 |
| Otsuka America Pharmaceutical, Inc. | 2 | $140 |
| ABBVIE INC. | 5 | $82 |
| Novo Nordisk Inc | 3 | $58 |
| Astellas Pharma US Inc | 2 | $43 |
| Bausch Health US, LLC | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| PFIZER INC. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: AIRSUPRA, REXULTI, BREZTRI, VRAYLAR, Ozempic, Veozah, WELLBUTRIN, CAPLYTA.
Industry payments across NJ — which companies pay providers there.
